REPORT
PATH, United States
Published: 01/12/2014
THEMES: Diagnostics | Drug-based Strategies | Financing & Economics | Leadership & Governance | Operational Research | Surveillance | Vaccines | Vector Control
$26.5M
$10.05M
$182,446
